| Jul 2 |
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
|
| Jul 2 |
Biggest stock movers today: PARA, INCY, and more
|
| Jul 1 |
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
|
| Jun 16 |
Incyte: The Worst Has Been Avoided
|
| Jun 14 |
Insider Sale: EVP & General Manager US Barry Flannelly Sells 19,164 Shares of Incyte Corp (INCY)
|
| Jun 13 |
Incyte Announces Final Results of Tender Offer
|
| Jun 11 |
Incyte tenders ~29.8M shares at $60.00 per share
|
| Jun 11 |
Incyte Announces Preliminary Results of Tender Offer
|
| Jun 7 |
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Jun 6 |
Agilent (A) Boosts Reach to Lab Researchers With New Devices
|
